Real-time enrollment status for this urinary tract infection clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:07 PM UTC
| NCT Number | NCT06672978 |
| Recruiting Status | Recruiting |
| Condition | Urinary Tract Infection |
| Phase | Clinical Trial |
| Target Enrollment | 66 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) |
| Last Updated on CT.gov | December 17, 2025 (Dec 17, 2025) |
As of March 2, 2026: Clinical trial NCT06672978 is currently recruiting participants. This clinical trial study for urinary tract infection is actively seeking new participants at 2 locations across the United States. The study is sponsored by Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06672978 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06672978 was last updated Dec 17, 2025 (December 17, 2025). HelloStudys verifies this status automatically.